BPC-157 + NAD+ Research Stack GI Repair + Mitochondrial Energy · Structural + Cellular Longevity Research · ≥99% HPLC · Janoshik COA
BPC-157 (stable gastric pentadecapeptide, NOS/VEGFR2/EGF repair signaling) and NAD+ (SIRT1-7 substrate, DNA repair cofactor, mitochondrial energy) represent complementary tissue repair and cellular longevity pathways. BPC-157 addresses structural tissue repair — angiogenesis, GI mucosal restoration, tendon healing. NAD+ addresses cellular energy maintenance, DNA repair capacity, and epigenetic regulation. Together they study repair from two distinct levels simultaneously. QSC stocks both at ≥99% HPLC with Janoshik COA.
PARP1/2 substrate → DNA strand break repair, genome stability
Complex I electron transport chain — mitochondrial ATP production
Declines ~50% between age 40-60 — one of the most well-documented aging biomarkers
NAD+ supplementation restores mitochondrial function in aged tissue models (Sinclair/Harvard research)
Frequently Asked Questions
Why combine BPC-157 and NAD+?
BPC-157 handles structural tissue repair (NOS/VEGF/EGF); NAD+ handles cellular energy and genome maintenance (SIRT/PARP). Complementary levels of the repair cascade — tissue signaling + cellular energy + DNA maintenance. QSC stocks both at ≥99% HPLC with Janoshik COA.
Does QSC stock NAD+?
Yes — QSC stocks NAD+ at ≥99% HPLC with Janoshik COA. Research use only.
Shop BPC-157 + NAD+ at QSC
≥99% HPLC · Janoshik COA · US-Based · Research Use Only
